ECT Q&A thread 23/7, page-8

This is the third time I have asked this series of questions dating back to your Q&A in June of which you never answered.

I have copied the post i made in entirety as the answers sought remain relevant.

I direct my questions based on your 2018 Annual Report to shareholders.

And I directly quote you:

“The first order of business under the project agreement is the finalisation and execution of a set of detailed sub-agreements, collectively termed the Research Collaboration Agreement (RCA), which form a condition precedent to financial close. The partners expect these agreements will be approved by the respective Boards and signed prior to the end of November 2018.”

“Notably, on 30 May we signed the Project Agreement which set the direction for the largest ever research and development (R&D) collaboration between Australia and India.”

“At the time of printing (early November) our India project is poised to proceed through ‘financial close’ upon signing of the detailed Research Collaboration Agreement (RCA), before the end of November 2018.”

“Given the significant amount of work involved over the past year in delivering the Project Agreement, and the expectation that we will sign the Research Collaboration Agreement during November, we anticipate and look forward to moving to a new and exciting stage in the development of our Company in the coming year.”

“The ELF was structured with all stakeholders’ interests in mind. ECT Finance created an offering which aimed to protect the existing entitlements of shareholders while also balancing the interests of those shareholders who were willing to contribute cash to the Company ahead of the ELF.”

“ECTF is planning for the market roll-out of the ELF structure, using the expertise and software that ECTF now has in place, and will update shareholders as outcomes progress”.

Questions:
1. Would you please upload an image of the front cover and header page of the Project Agreement.
2. Would you please upload an image of the front cover and header page of the Research Collaboration Agreement (s).
3. Would you please explain how the condition precedents to financial close evaporated?
4. Would you please explain what particular information gave you sufficient confidence to state that the alleged agreements were poised to be signed before the end of November 2018?
5.What was the most significant piece of work by an individual at ECT that lead you to believe that the alleged agreements would be signed?
6. Do you believe that ECT Finance and the ELF structure has protected the existing entitlements of shareholders and balanced the interests of those shareholders who were willing to contribute cash on the basis of statements made in the 2018 Annual Report?
7.What market roll out of the ELF structure occurred following your statements made in the 2018 Annual Report?

Thank you.